• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cognition, Statins, and Cholesterol in Elderly Ischemic Stroke Patients: A Neurologist's Perspective.认知功能、他汀类药物和老年缺血性脑卒中患者的胆固醇:神经科医生的观点。
Medicina (Kaunas). 2021 Jun 13;57(6):616. doi: 10.3390/medicina57060616.
2
MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke.MoCA、ACE-R 和 MMSE 与 NINDS-CSN 血管性认知障碍协调标准神经心理学成套测验在 TIA 和卒中后的比较。
Stroke. 2012 Feb;43(2):464-9. doi: 10.1161/STROKEAHA.111.633586. Epub 2011 Dec 8.
3
Association of the ASCO classification with the executive function subscores of the Montreal cognitive assessment in patients with postischemic stroke.缺血性中风患者中美国临床肿瘤学会(ASCO)分类与蒙特利尔认知评估执行功能子评分的相关性
J Stroke Cerebrovasc Dis. 2014 Oct;23(9):2250-5. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.009. Epub 2014 Aug 27.
4
Differences in cognitive profile between TIA, stroke and elderly memory research subjects: a comparison of the MMSE and MoCA.短暂性脑缺血发作、卒中和老年记忆研究对象认知特征的差异:MMSE 和 MoCA 的比较。
Cerebrovasc Dis. 2012;34(1):48-54. doi: 10.1159/000338905. Epub 2012 Jun 29.
5
Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment.验证中文版 Addenbrooke's 认知测验 III 用于检测轻度认知障碍。
Aging Ment Health. 2022 Feb;26(2):384-391. doi: 10.1080/13607863.2021.1881757. Epub 2021 Feb 3.
6
Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack.缺血性中风或短暂性脑缺血发作患者的血脂谱测定及他汀类药物的使用。
Stroke. 2003 Jan;34(1):105-10. doi: 10.1161/01.str.0000048865.79221.4d.
7
The use of MMSE and MoCA in patients with acute ischemic stroke in clinical.简易精神状态检查表(MMSE)和蒙特利尔认知评估量表(MoCA)在急性缺血性脑卒中患者临床中的应用。
Int J Neurosci. 2016;126(5):442-7. doi: 10.3109/00207454.2015.1031749. Epub 2015 Sep 25.
8
Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study.在短暂性脑缺血发作和中风患者中,与蒙特利尔认知评估相比,简易精神状态检查低估了认知障碍:一项基于人群的研究。
Stroke. 2010 Jun;41(6):1290-3. doi: 10.1161/STROKEAHA.110.579888. Epub 2010 Apr 8.
9
Cognitive assessment in proximity to acute ischemic stroke/transient ischemic attack: comparison of the montreal cognitive assessment test and mindstreams computerized cognitive assessment battery.急性缺血性卒中和短暂性脑缺血发作患者的认知评估:蒙特利尔认知评估量表与思睿明电脑化认知评估系统的比较。
Dement Geriatr Cogn Disord. 2013;36(1-2):36-42. doi: 10.1159/000350035. Epub 2013 May 23.
10
Statin treatment in stroke patient with low-density lipoprotein cholesterol levels below 70 mg/dL.他汀类药物治疗 LDL-C 水平低于 70mg/dL 的卒中患者。
J Stroke Cerebrovasc Dis. 2024 May;33(5):107645. doi: 10.1016/j.jstrokecerebrovasdis.2024.107645. Epub 2024 Feb 21.

引用本文的文献

1
Is Targeting LDL-C Levels Below 70 mg/dL Beneficial for Cardiovascular and Overall Health? A Critical Examination of the Evidence.将低密度脂蛋白胆固醇(LDL-C)水平降至70mg/dL以下对心血管和整体健康有益吗?对证据的批判性审视。
J Clin Med. 2025 May 20;14(10):3569. doi: 10.3390/jcm14103569.
2
Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke.缺血性脑卒中后认知功能障碍发生发展中代谢紊乱机制及标志物的研究进展
Front Endocrinol (Lausanne). 2025 Jan 22;16:1500650. doi: 10.3389/fendo.2025.1500650. eCollection 2025.
3
Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy.关于使用相对风险统计数据描述高LDL胆固醇的所谓危害及降脂治疗益处的历史回顾。
Cureus. 2023 May 1;15(5):e38391. doi: 10.7759/cureus.38391. eCollection 2023 May.
4
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer's Disease Progression.衰老和阿尔茨海默病进展中的神经炎症分子机制。
Int J Mol Sci. 2023 Jan 18;24(3):1869. doi: 10.3390/ijms24031869.
5
Cholesterol Management in Neurology: Time for Revised Strategies?神经病学中的胆固醇管理:是时候修订策略了吗?
J Pers Med. 2022 Nov 30;12(12):1981. doi: 10.3390/jpm12121981.
6
Importance of Coagulation Factors as Critical Components of Premature Cardiovascular Disease in Familial Hypercholesterolemia.凝血因子在家族性高胆固醇血症患者早发心血管疾病中的重要性。
Int J Mol Sci. 2022 Aug 15;23(16):9146. doi: 10.3390/ijms23169146.
7
Molecular Pathophysiological Mechanisms in Huntington's Disease.亨廷顿舞蹈症的分子病理生理机制
Biomedicines. 2022 Jun 17;10(6):1432. doi: 10.3390/biomedicines10061432.
8
Oxidative Stress in Ischemia/Reperfusion Injuries following Acute Ischemic Stroke.急性缺血性卒中后缺血/再灌注损伤中的氧化应激
Biomedicines. 2022 Mar 1;10(3):574. doi: 10.3390/biomedicines10030574.
9
Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies.脑缺血及缺血/再灌注损伤中的神经炎症:从病理生理学到治疗策略
Int J Mol Sci. 2021 Dec 21;23(1):14. doi: 10.3390/ijms23010014.

本文引用的文献

1
Impact of lipophilic vs hydrophilic statins on the clinical outcome and biomarkers of remodelling in heart failure patients: A prospective comparative randomized study.亲脂性与亲水性他汀类药物对心力衰竭患者临床结局和重塑生物标志物的影响:一项前瞻性比较随机研究。
Br J Clin Pharmacol. 2021 Jul;87(7):2855-2866. doi: 10.1111/bcp.14695. Epub 2021 Jan 3.
2
Low LDL-C Levels: Likely No Short-Term Cognitive Harm.低密度脂蛋白胆固醇(LDL-C)水平低:短期内可能不会对认知造成损害。
J Am Coll Cardiol. 2020 May 12;75(18):2294-2296. doi: 10.1016/j.jacc.2020.03.040.
3
Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.联合使用他汀类药物和抗高血压药物治疗与降低阿尔茨海默病及相关痴呆症风险相关。
PLoS One. 2020 Mar 4;15(3):e0229541. doi: 10.1371/journal.pone.0229541. eCollection 2020.
4
Oxidative Stress in the Pathogenesis of Alzheimer's Disease and Cerebrovascular Disease with Therapeutic Implications.氧化应激在阿尔茨海默病和脑血管病发病机制中的作用及其治疗意义。
CNS Neurol Disord Drug Targets. 2020;19(2):94-108. doi: 10.2174/1871527319666200303121016.
5
Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke.缺血性卒中风后 5 年内 LDL(低密度脂蛋白)胆固醇<70mg/dL 的获益。
Stroke. 2020 Apr;51(4):1231-1239. doi: 10.1161/STROKEAHA.119.028718. Epub 2020 Feb 20.
6
Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta-Analysis.他汀类药物在痴呆患者中的获益与危害:系统评价和荟萃分析。
J Am Geriatr Soc. 2020 Mar;68(3):650-658. doi: 10.1111/jgs.16342. Epub 2020 Feb 10.
7
Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018.2018年11月11日至13日于斯德哥尔摩举行的欧洲卒中组织-卡罗林斯卡卒中最新进展会议的共识声明与建议
Eur Stroke J. 2019 Dec;4(4):307-317. doi: 10.1177/2396987319863606. Epub 2019 Sep 2.
8
Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205].《2019 ESC/EAS血脂异常管理指南:降低心血管风险的血脂修饰》勘误 [《动脉粥样硬化》290 (2019) 140 - 205]
Atherosclerosis. 2020 Jan;292:160-162. doi: 10.1016/j.atherosclerosis.2019.11.020. Epub 2019 Dec 4.
9
Association between Use of Statin and Risk of Dementia: A Meta-Analysis of Observational Studies.他汀类药物使用与痴呆风险的关联:观察性研究的荟萃分析。
Neuroepidemiology. 2020;54(3):214-226. doi: 10.1159/000503105. Epub 2019 Oct 1.
10
Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial.依折麦布降脂预防 75 岁及以上动脉粥样硬化性心血管疾病试验(EWTOPIA 75):一项随机对照试验。
Circulation. 2019 Sep 17;140(12):992-1003. doi: 10.1161/CIRCULATIONAHA.118.039415. Epub 2019 Aug 22.

认知功能、他汀类药物和老年缺血性脑卒中患者的胆固醇:神经科医生的观点。

Cognition, Statins, and Cholesterol in Elderly Ischemic Stroke Patients: A Neurologist's Perspective.

机构信息

Department of Psycho-Neurosciences and Rehabilitation, Faculty of Medicine and Pharmacy, University of Oradea, nr 1 Universitatii Street, 410087 Oradea, Romania.

Neurology Ward, Clinical Municipal Hospital "dr. G. Curteanu", nr 12 Corneliu Coposu Street, 410469 Oradea, Romania.

出版信息

Medicina (Kaunas). 2021 Jun 13;57(6):616. doi: 10.3390/medicina57060616.

DOI:10.3390/medicina57060616
PMID:34199243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8231765/
Abstract

The efficacy of hydroxy methyl glutaryl-coenzyme A reductase inhibitors (statins) in reducing the incidence of cardiovascular events pushed the target LDL-cholesterol (LDL-C) levels lower and lower in successive guidelines despite signals regarding potential cognitive side effects. We evaluated the relationship between cognitive impairment and LDL-C levels in elderly ischemic stroke patients. 29 ischemic stroke patients aged 65 and above with LDL-C levels ≤70 mg/dL, classified according to the TOAST criteria, underwent detailed neuropsychological testing comprising the MMSE test, Montreal Cognitive Assessment (MoCA) and Addenbrooke's Cognitive Evaluation (ACE-III) test. Their performances were compared to those of 29 age-matched ischemic stroke patients with LDL-Cl levels >71 mg/dL. The MMSE test failed to detect significant cognitive differences between the two groups. The MoCA and ACE-III tests detected impairments in visuo-spatial/executive function, attention, and recall/memory in patients with low LDL-C. A stepwise linear regression model of the ACE-III total scores revealed that LDL-cholesterol levels could contribute to 13.8% of the detected cognitive dysfunction, second in importance only to age, which contributed to 38.8% of the detected impairment. Physicians should be cautious when prescribing statins to elderly people. Hydrophilic ones may be preferred in cognitively impaired patients.

摘要

羟甲基戊二酰辅酶 A 还原酶抑制剂(他汀类药物)在降低心血管事件发生率方面的疗效,促使连续指南中的 LDL-胆固醇(LDL-C)目标水平越来越低,尽管有关于潜在认知副作用的信号。我们评估了认知障碍与老年缺血性脑卒中患者 LDL-C 水平之间的关系。 根据 TOAST 标准,29 名年龄在 65 岁及以上且 LDL-C 水平≤70mg/dL 的缺血性脑卒中患者接受了详细的神经心理学测试,包括 MMSE 测试、蒙特利尔认知评估(MoCA)和 Addenbrooke 认知评估(ACE-III)测试。将他们的表现与 29 名 LDL-C 水平>71mg/dL 的年龄匹配的缺血性脑卒中患者进行比较。 MMSE 测试未能检测到两组之间存在显著的认知差异。MoCA 和 ACE-III 测试检测到低 LDL-C 患者在视空间/执行功能、注意力和回忆/记忆方面存在障碍。ACE-III 总分的逐步线性回归模型显示,LDL-胆固醇水平可导致 13.8%的认知功能障碍,仅次于仅占 38.8%的年龄因素。 医生在为老年人开他汀类药物时应谨慎。在认知障碍患者中,亲水他汀类药物可能更受欢迎。